Myers CE - Search Results

1

Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables.

Dawson NA, Cooper MR, Figg WD, Headlee DJ, Thibault A, Bergan RC, Steinberg SM, Sausville EA, Myers CE, Sartor O. Dawson NA, et al. Among authors: myers ce. Cancer. 1995 Aug 1;76(3):453-62. doi: 10.1002/1097-0142(19950801)76:3<453::aid-cncr2820760316>3.0.co;2-e. Cancer. 1995. PMID: 8625127 Clinical Trial.

2

Suramin in advanced platinum-resistant ovarian cancer.

Reed E, Cooper MR, LaRocca RV, Bostick-Bruton F, Myers CE. Reed E, et al. Among authors: myers ce. Eur J Cancer. 1992;28A(4-5):864-6. doi: 10.1016/0959-8049(92)90135-o. Eur J Cancer. 1992. PMID: 1524910 Clinical Trial.

3

Adaptive control with feedback strategies for suramin dosing.

Cooper MR, Lieberman R, La Rocca RV, Gernt PR, Weinberger MS, Headlee DJ, Kohler DR, Goldspiel BR, Peck CC, Myers CE. Cooper MR, et al. Among authors: myers ce. Clin Pharmacol Ther. 1992 Jul;52(1):11-23. doi: 10.1038/clpt.1992.97. Clin Pharmacol Ther. 1992. PMID: 1623689 Clinical Trial.

4

A pilot study of suramin in the treatment of metastatic renal cell carcinoma.

La Rocca RV, Stein CA, Danesi R, Cooper MR, Uhrich M, Myers CE. La Rocca RV, et al. Among authors: myers ce. Cancer. 1991 Mar 15;67(6):1509-13. doi: 10.1002/1097-0142(19910315)67:6<1509::aid-cncr2820670608>3.0.co;2-f. Cancer. 1991. PMID: 2001538

5

Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of "hormone-refractory" prostate cancer.

Sartor O, Cooper M, Weinberger M, Headlee D, Thibault A, Tompkins A, Steinberg S, Figg WD, Linehan WM, Myers CE. Sartor O, et al. Among authors: myers ce. J Natl Cancer Inst. 1994 Feb 2;86(3):222-7. doi: 10.1093/jnci/86.3.222. J Natl Cancer Inst. 1994. PMID: 7506794

6

Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer.

Figg WD, Sartor O, Cooper MR, Thibault A, Bergan RC, Dawson N, Reed E, Myers CE. Figg WD, et al. Among authors: myers ce. Am J Med. 1995 Apr;98(4):412-4. doi: 10.1016/S0002-9343(99)80323-4. Am J Med. 1995. PMID: 7535978 Clinical Trial. No abstract available.

7

Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin.

Bitton RJ, Figg WD, Venzon DJ, Dalakas MC, Bowden C, Headlee D, Reed E, Myers CE, Cooper MR. Bitton RJ, et al. Among authors: myers ce. J Clin Oncol. 1995 Sep;13(9):2223-9. doi: 10.1200/JCO.1995.13.9.2223. J Clin Oncol. 1995. PMID: 7666080 Clinical Trial.

8

Phase I study of phenylacetate administered twice daily to patients with cancer.

Thibault A, Samid D, Cooper MR, Figg WD, Tompkins AC, Patronas N, Headlee DJ, Kohler DR, Venzon DJ, Myers CE. Thibault A, et al. Among authors: myers ce. Cancer. 1995 Jun 15;75(12):2932-8. doi: 10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>3.0.co;2-p. Cancer. 1995. PMID: 7773944 Clinical Trial.

9

In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrate.

Figg WD, Walls RG, Cooper MR, Thibault A, Sartor O, McCall NA, Myers CE, Samid D. Figg WD, et al. Among authors: myers ce. Anticancer Drugs. 1994 Jun;5(3):336-42. doi: 10.1097/00001813-199406000-00012. Anticancer Drugs. 1994. PMID: 7919459

10

Anaphylactoid reaction with suramin.

Thibault A, Figg WD, Cooper MR, Prindiville SA, Sartor AO, Headlee DJ, Myers CE. Thibault A, et al. Among authors: myers ce. Pharmacotherapy. 1993 Nov-Dec;13(6):656-7. Pharmacotherapy. 1993. PMID: 8302692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters